Active Ingredient: EPLONTERSEN SODIUM
Proprietary Name: WAINUA (AUTOINJECTOR)
Dosage Form; Route of Administration: SOLUTION; SUBCUTANEOUS
Strength: EQ 45MG BASE/0.8ML (EQ 45MG BASE/0.8ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N217388
Product Number: 001
Approval Date: Dec 21, 2023
Applicant Holder Full Name: ASTRAZENECA AB
Marketing Status:
Prescription
Patent and Exclusivity Information
